BISOVA is purpose-built for pharma and healthcare compliance teams. It combines deep tech and proprietary enterprise AI, protected by a provisional patent, to give compliance leaders the intelligence their teams demand. This is a first-mover position in a market ready for a new standard.
BISOVA is patent pending. Haliya is represented by Big Law attorneys at Morgan Lewis LLP, covering IP protection, corporate structuring, and pharma compliance matters.
The demo is live. Design partners and qualified investors are welcome to connect with the founding team directly.
The BISOVA demo is ready. Schedule a private walkthrough with the founding team and see the product firsthand.
For pharma compliance leaders and qualified investors
Details available to qualified investors and strategic partners under a mutual NDA.
Haliya is in active conversations with venture capitalists and a big pharmaceutical CEO. First customers are being onboarded. Design partnerships are advancing. The round is closing. As a Berkeley SkyDeck Batch 23 company, Haliya is backed by one of the world's most selective startup programs. The founding team is executing at full pace. This is the moment to get in.
Haliya is raising $3M. Qualified investors and pharma and healthcare compliance leaders are invited to connect directly with the founding team.
The BISOVA demo is ready. Request access below.
Responses within 2 business days · michaela@haliya.ai